Literature DB >> 23434099

RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis.

David M Sisul1, Michael A Liss, Kerrin L Palazzi, Kaitlan Briles, Reza Mehrazin, Robert E Gold, James H Masterson, Hossein S Mirheydar, Ramzi Jabaji, Sean P Stroup, James O L'Esperance, Robert W Wake, Gerant Rivera-Sanfeliz, Ithaar H Derweesh.   

Abstract

OBJECTIVE: To analyze outcomes and complications of percutaneous (PRC) and laparoscopic renal cryoablation (LRC) using the radius, endophytic, nearness to collecting system, anterior/posterior, and location (RENAL) nephrometry system.
METHODS: Retrospective multicenter analysis of 154 consecutive patients who underwent either ultrasound-guided LRC (n = 88) or computed tomography (CT)-guided PRC (n = 66) from March 2003 to December 2011. RENAL score and demographics were compared to postoperative complications (Clavien). Multivariable analysis was carried out for factors associated with development of postprocedure complications.
RESULTS: Mean age was 68 years (94 men/60 women). Median follow-up was 34 months (range 23.6-45.6 months). Mean tumor size was 2.6 ± 1 cm. Mean RENAL score was 5.2 ± 1.4. Differences in (A)nterior/posterior component and (H)ilar domain of the RENAL scores were noted, with PRC favoring posterior tumors and hilar lesions compared to LRC (P < .001 and P = .044, respectively). There were 14.9% complications, all of which were low-grade (Clavien 1,2). There were no differences in complications between LRC and PRC (15.9% vs 13.6%, P = .82). Most common complication type was hemorrhagic in 9 of 154 patients (5.8%); significant increase in the hemorrhagic complication rate was noted for patients with "N" ("nearness") component score of 2 or 3 (5/36, or 13.9%), compared to patients with "N" score of 1 (4/115 or 3.5%, P = .033). multivariable analysis demonstrated that increasing RENAL score was associated with postprocedure complications (odds ratio [OR] = 1.37, P = .025). When separated into individual domains, multivariable analysis revealed that "N" score 3 was significantly associated with postoperative complications (OR 16.15, P = .027).
CONCLUSION: Increasing RENAL score was associated development of postprocedure complications after renal cryotherapy. Further investigation is requisite to elucidate the role of RENAL nephrometry score in risk stratification prior to renal cryotherapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23434099     DOI: 10.1016/j.urology.2012.11.037

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours.

Authors:  Alexandra Leora Millman; Kenneth T Pace; Michael Ordon; Jason Young Lee
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 2.  Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends.

Authors:  K Farrag; S Sriprasad
Journal:  Indian J Surg Oncol       Date:  2016-12-15

3.  Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.

Authors:  Anna Maria Ierardi; Alessio Puliti; Salvatore Alessio Angileri; Mario Petrillo; Ejona Duka; Chiara Floridi; Michela Lecchi; Gianpaolo Carrafiello
Journal:  Med Oncol       Date:  2017-04-19       Impact factor: 3.064

Review 4.  Update on cryoablation for treatment of small renal mass: oncologic control, renal function preservation, and rate of complications.

Authors:  Anil Kapoor; Yuding Wang; Brad Dishan; Stephen E Pautler
Journal:  Curr Urol Rep       Date:  2014-04       Impact factor: 3.092

Review 5.  Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging.

Authors:  Winston B Joe; Jessica G Zarzour; Andrew J Gunn
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

Review 6.  Ablative therapies for small renal tumours.

Authors:  Arturo Castro; Lawrence C Jenkins; Nelson Salas; Gideon Lorber; Raymond J Leveillee
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

Review 7.  The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.

Authors:  Tobias Klatte; Nils Kroeger; Uwe Zimmermann; Martin Burchardt; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

8.  Kidney cancer focal cryoablation trend: does location or approach matter?

Authors:  O Rodriguez Faba; F Sanguedolce; P Grange; G Kooiman; A Bakavicius; P De la Torre; J Palou
Journal:  World J Urol       Date:  2015-10-26       Impact factor: 4.226

9.  Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition.

Authors:  Thierry Krummel; Julien Garnon; Hervé Lang; Afshin Gangi; Thierry Hannedouche
Journal:  BMC Urol       Date:  2014-09-25       Impact factor: 2.264

Review 10.  Laparoscopic ultrasonography: The wave of the future in renal cell carcinoma?

Authors:  Bitian Liu; Yunhong Zhan; Xiaonan Chen; Qingpeng Xie; Bin Wu
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.